Repligen - 29 Year Stock Price History | RGEN

Historical daily share price chart and data for Repligen since 1990 adjusted for splits. The latest closing stock price for Repligen as of September 13, 2019 is 79.74.
  • The all-time high Repligen stock closing price was 95.51 on August 01, 2019.
  • The Repligen 52-week high stock price is 99.25, which is 24.5% above the current share price.
  • The Repligen 52-week low stock price is 48.26, which is 39.5% below the current share price.
  • The average Repligen stock price for the last 52 weeks is 67.11.
Repligen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 70.7645 51.6900 95.5100 49.4500 79.7400 51.19%
2018 46.6978 37.0600 68.8800 30.9200 52.7400 45.37%
2017 36.9658 31.1500 46.0600 28.8200 36.2800 17.72%
2016 27.8137 28.1000 33.9800 20.9300 30.8200 8.94%
2015 31.9389 20.1000 42.1400 19.8600 28.2900 42.88%
2014 18.9447 12.6300 25.4900 12.3000 19.8000 45.16%
2013 9.2758 6.6300 13.6400 5.9800 13.6400 117.20%
2012 4.9963 3.5000 7.2600 3.4200 6.2800 80.98%
2011 3.7511 4.5200 5.3400 3.1100 3.4700 -26.01%
2010 3.5501 4.0400 4.7500 3.1300 4.6900 14.11%
2009 4.6107 3.9200 5.5500 3.5600 4.1100 8.73%
2008 5.0503 6.6500 6.8600 3.3000 3.7800 -42.29%
2007 3.9288 2.8000 6.5500 2.8000 6.5500 133.10%
2006 3.3184 3.9000 4.9900 2.2700 2.8100 -29.75%
2005 2.5936 2.9000 4.0000 1.6700 4.0000 38.89%
2004 2.4385 4.1600 4.1600 1.3200 2.8800 -34.10%
2003 5.1839 2.9700 8.2610 2.7600 4.3700 43.75%
2002 2.7848 2.6900 4.3800 2.1100 3.0400 24.79%
2001 2.8083 3.5630 5.6560 1.3400 2.4360 -27.82%
2000 6.6213 3.0630 16.6300 3.0000 3.3750 8.00%
1999 2.7662 1.3750 4.7500 1.2500 3.1250 143.95%
1998 1.3729 1.0310 3.0000 0.9688 1.2810 63.96%
1997 1.1450 1.2190 1.7500 0.7188 0.7813 -34.34%
1996 1.1393 1.0600 1.5625 0.5000 1.1900 5.78%
1995 1.7766 1.8750 3.0630 1.0000 1.1250 -35.71%
1994 4.1901 7.0000 8.0000 1.7500 1.7500 -74.55%
1993 7.2480 9.5000 10.5000 5.5000 6.8750 -27.63%
1992 12.7509 17.0000 20.1300 8.0000 9.5000 -38.71%
1991 14.3425 12.0000 29.0000 10.3800 15.5000 24.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.071B $0.194B
Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are a leading manufacturer of Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. They also supply several growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, they have developed and marketed their OPUS? series of pre-packed `plug-and-play` chromatography columns, and they provide test kits to ensure final product quality. Aside from their core bioprocessing business, they have a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and an orphan drug candidate in Phase 1 development.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.342B 13.25
Gilead Sciences (GILD) United States $84.042B 10.32
CSL (CSLLY) Australia $72.428B 0.00
Celgene (CELG) United States $69.903B 10.81
Vertex Pharmaceuticals (VRTX) United States $44.326B 47.90
Illumina (ILMN) United States $43.735B 51.38
Biogen (BIIB) United States $42.849B 7.61
Regeneron Pharmaceuticals (REGN) United States $31.212B 14.17
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.275B 12.80
SINO PHARMACEUT (SBMFF) China $17.750B 0.00
Incyte (INCY) United States $16.360B 48.15
Exact Sciences (EXAS) United States $14.074B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.065B 0.00
Genmab (GNMSF) Denmark $12.366B 69.36
Seattle Genetics (SGEN) United States $11.463B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.123B 54.27
Alnylam Pharmaceuticals (ALNY) United States $9.249B 0.00
Galapagos (GLPG) Belgium $8.775B 0.00
QIAGEN (QGEN) Netherlands $7.685B 25.24
Bio-Techne Corp (TECH) United States $7.575B 52.33
Guardant Health (GH) United States $7.163B 0.00
Sarepta Therapeutics (SRPT) United States $6.540B 0.00
BeiGene (BGNE) Cayman Islands $6.319B 0.00
Amarin (AMRN) Ireland $5.983B 0.00
Exelixis (EXEL) United States $5.834B 15.16
Bluebird Bio (BLUE) United States $5.699B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.655B 0.00
Moderna (MRNA) United States $5.415B 0.00
Horizon Pharma Public (HZNP) Ireland $4.928B 12.53
ARGENX SE-ADR (ARGX) Netherlands $4.772B 0.00
Ascendis Pharma (ASND) Denmark $4.406B 0.00
Spark Therapeutics (ONCE) United States $4.066B 0.00
China Biologic Products (CBPO) China $3.934B 24.56
Blueprint Medicines (BPMC) United States $3.880B 0.00
Medicines (MDCO) United States $3.852B 0.00
MorphoSys AG (MOR) Germany $3.692B 0.00
Alkermes (ALKS) Ireland $3.554B 0.00
Mirati Therapeutics (MRTX) United States $3.329B 0.00
Immunomedics (IMMU) United States $3.018B 0.00
Emergent Biosolutions (EBS) United States $2.794B 41.97
Genomic Health (GHDX) United States $2.710B 50.82
CRISPR Therapeutics AG (CRSP) Switzerland $2.626B 0.00
Arena Pharmaceuticals (ARNA) United States $2.620B 5.63
Ultragenyx Pharmaceutical (RARE) United States $2.578B 0.00
Reata Pharmaceuticals (RETA) United States $2.564B 0.00
MyoKardia (MYOK) United States $2.541B 0.00
Amicus Therapeutics (FOLD) United States $2.493B 0.00
Acceleron Pharma (XLRN) United States $2.434B 0.00
Halozyme Therapeutics (HALO) United States $2.413B 0.00
NeoGenomics (NEO) United States $2.342B 125.28
Intercept Pharmaceuticals (ICPT) United States $2.226B 0.00
Myriad Genetics (MYGN) United States $2.040B 21.41
Cambrex (CBM) United States $2.010B 25.41
Zai Lab (ZLAB) China $1.964B 0.00
Akcea Therapeutics (AKCA) United States $1.957B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.863B 0.00
Ligand Pharmaceuticals (LGND) United States $1.855B 23.45
UniQure (QURE) Netherlands $1.838B 0.00
Denali Therapeutics (DNLI) United States $1.826B 0.00
Insmed (INSM) United States $1.696B 0.00
REGENXBIO (RGNX) United States $1.456B 0.00
Coherus BioSciences (CHRS) United States $1.391B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.369B 0.00
Alector (ALEC) United States $1.346B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.345B 0.00
Editas Medicine (EDIT) United States $1.292B 0.00
Sangamo Therapeutics (SGMO) United States $1.285B 0.00
RA PHARMCTL INC (RARX) United States $1.178B 0.00
Innoviva (INVA) United States $1.176B 3.39
AnaptysBio (ANAB) United States $1.159B 0.00
Fate Therapeutics (FATE) United States $1.141B 0.00
Epizyme (EPZM) United States $1.105B 0.00
Athenex (ATNX) United States $1.085B 0.00
Zymeworks (ZYME) Canada $1.022B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.016B 0.00
Twist Bioscience (TWST) United States $0.941B 0.00
Cara Therapeutics (CARA) United States $0.921B 0.00
Principia Biopharma (PRNB) United States $0.882B 459.75
Arvinas (ARVN) United States $0.879B 0.00
ANI Pharmaceuticals (ANIP) United States $0.877B 14.64
BAVARIAN NORDIC (BVNRY) Denmark $0.843B 0.00
Codexis (CDXS) United States $0.829B 0.00
WAVE Life Sciences (WVE) Singapore $0.826B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.815B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.771B 0.00
Anika Therapeutics (ANIK) United States $0.756B 26.76
Cytokineticsorporated (CYTK) United States $0.739B 0.00
Zealand Pharma (ZEAL) Denmark $0.734B 8.51
Vericel (VCEL) United States $0.729B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.727B 26.25
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Intellia Therapeutics (NTLA) United States $0.721B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Mesoblast (MESO) Australia $0.636B 0.00
DBV Technologies S.A (DBVT) France $0.578B 0.00
Intra-Cellular Therapies (ITCI) United States $0.577B 0.00
Revance Therapeutics (RVNC) United States $0.572B 0.00
MiMedx (MDXG) United States $0.561B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.557B 0.00
Cellectis S.A (CLLS) France $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Precision BioSciences (DTIL) United States $0.506B 0.00
Retrophin (RTRX) United States $0.504B 0.00
Heska (HSKA) United States $0.500B 64.82
Autolus Therapeutics (AUTL) United Kingdom $0.498B 0.00
Syros Pharmaceuticals (SYRS) United States $0.492B 0.00
Stemline Therapeutics (STML) United States $0.480B 0.00
UROGEN PHARMA (URGN) United States $0.474B 0.00
PHARMA MAR SA (PHMMF) Spain $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.459B 0.00
Puma Biotechnology (PBYI) United States $0.451B 0.00
CytomX Therapeutics (CTMX) United States $0.440B 0.00
BioDelivery Sciences (BDSI) United States $0.424B 0.00
Agenus (AGEN) United States $0.422B 0.00
Arcus Biosciences (RCUS) United States $0.418B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.415B 0.00
Bellus Health (BLU) Canada $0.395B 0.00
Scholar Rock Holding (SRRK) United States $0.388B 0.00
Merus (MRUS) Netherlands $0.385B 0.00
Adverum Biotechnologies (ADVM) United States $0.384B 0.00
Protagonist Therapeutics (PTGX) United States $0.382B 0.00
Gritstone Oncology (GRTS) United States $0.365B 0.00
Kadmon Holdings (KDMN) United States $0.363B 0.00
AC Immune SA (ACIU) Switzerland $0.355B 26.25
Prothena (PRTA) Ireland $0.348B 0.00
Theratechnologies (THERF) Canada $0.325B 0.00
Biofrontera AG (BFRA) Germany $0.319B 477.09
Albireo Pharma (ALBO) United States $0.318B 0.00
Clovis Oncology (CLVS) United States $0.312B 0.00
ADMA Biologics Inc (ADMA) United States $0.310B 0.00
Dynavax Technologies (DVAX) United States $0.309B 0.00
Sorrento Therapeutics (SRNE) United States $0.304B 0.00
Avid Bioservices (CDMO) United States $0.304B 0.00
Geron (GERN) United States $0.298B 0.00
Starpharma Holdings (SPHRY) Australia $0.285B 0.00
Cellular Biomedicine (CBMG) United States $0.280B 0.00
Kindred Biosciences (KIN) United States $0.276B 0.00
MannKind (MNKD) United States $0.271B 0.00
PDL BioPharma (PDLI) United States $0.271B 6.97
Seres Therapeutics (MCRB) United States $0.270B 0.00
Prometic Life Sciences (PFSCF) Canada $0.266B 0.00
Inovio Pharmaceuticals (INO) United States $0.258B 0.00
Senesco Technologies (ELOX) United States $0.258B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.257B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.256B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.251B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.246B 0.00
Sutro Biopharma (STRO) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.240B 0.00
Spero Therapeutics (SPRO) United States $0.232B 0.00
ChromaDex (CDXC) United States $0.231B 0.00
Athersys (ATHX) United States $0.226B 0.00
Five Prime Therapeutics (FPRX) United States $0.215B 0.00
Kamada (KMDA) Israel $0.213B 8.12
Compugen (CGEN) Israel $0.210B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.202B 0.00
Cue Biopharma (CUE) United States $0.199B 0.00
EXICURE INC (XCUR) United States $0.195B 0.00
Affimed (AFMD) Germany $0.195B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.191B 0.00
OSMOTICA PHARM (OSMT) United States $0.191B 0.00
Acorda Therapeutics (ACOR) United States $0.185B 0.00
Arsanis (XFOR) United States $0.184B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.182B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
XOMA (XOMA) United States $0.168B 0.00
POXEL SA FRANCE (PXXLF) France $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Emmaus Life Sciences (EMMA) United States $0.163B 0.00
Northwest Biotherapeutics (NWBO) United States $0.163B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.162B 0.00
Nicox SA (NICXF) France $0.161B 0.00
Cerecor (CERC) United States $0.161B 0.00
Abeona Therapeutics (ABEO) United States $0.155B 0.00
Alcobra (ARCT) United States $0.152B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
PHASEBIO PHARMA (PHAS) United States $0.147B 0.00
Strongbridge Biopharma (SBBP) United States $0.146B 6.00
Dyadic (DYAI) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Novavax (NVAX) United States $0.137B 0.00
Aptinyx (APTX) United States $0.134B 0.00
NantKwest (NK) United States $0.131B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.128B 0.00
Menlo Therapeutics (MNLO) United States $0.126B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.109B 0.00
Aduro Biotech (ADRO) United States $0.107B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.106B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Verastem (VSTM) United States $0.097B 0.00
Mersana Therapeutics (MRSN) United States $0.096B 0.00
Arbutus Biopharma (ABUS) Canada $0.093B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
VTv Therapeutics (VTVT) United States $0.087B 0.00
Idera Pharmaceuticals (IDRA) United States $0.087B 0.00
Trevena (TRVN) United States $0.086B 0.00
Synlogic (SYBX) United States $0.083B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
OvaScience (MLND) United States $0.079B 0.00
Liquidia Technologies (LQDA) United States $0.077B 0.00
Catalyst Biosciences (CBIO) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.073B 0.00
VBI Vaccines (VBIV) United States $0.072B 0.00
NewLink Genetics (NLNK) United States $0.072B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.068B 37.30
Curis (CRIS) United States $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.066B 0.00
ARAVIVE, INC (ARAV) United States $0.065B 0.00
AquaBounty Technologies (AQB) United States $0.065B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Unum Therapeutics (UMRX) United States $0.062B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.059B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
AIT Therapeutics (XAIR) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.049B 0.00
Ophthotech (ISEE) United States $0.049B 0.00
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Proteostasis Therapeutics (PTI) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Stellar Biotechnologies (EDSA) Canada $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.033B 0.00
AEterna Zentaris (AEZS) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
TOCAGEN INC (TOCA) United States $0.022B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.10
Pulmatrix (PULM) United States $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
Novelion Therapeutics (NVLN) Canada $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00